Cargando…

Sustained systemic response paralleled with ovarian metastasis progression by sunitinib in metastatic renal cell carcinoma: Is this an anti-angiogenic potentiation of cancer?

Metastatic renal cell cancer is associated with poor prognosis and survival and is resistant to conventional chemotherapy. Therapeutic targeting of molecular pathways for tumor angiogenesis and other specific activation mechanisms offers improved tumor response and prolonged survival. A 48-year-old,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mete, Uttam K., Singh, Dig Vijay, Kakkar, Nandita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518383/
https://www.ncbi.nlm.nih.gov/pubmed/26229334
http://dx.doi.org/10.4103/0974-7796.153669